Latest Insider Transactions at Atara Biotherapeutics, Inc. (ATRA)
This section provides a real-time view of insider transactions for Atara Biotherapeutics, Inc. (ATRA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Atara Biotherapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Atara Biotherapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 02
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
1,665
-1.16%
|
$26,640
$16.74 P/Share
|
|
Mar 01
2021
|
Pascal Touchon President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
117,187
+23.93%
|
-
|
|
Mar 01
2021
|
Utpal Koppikar Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,258
+20.47%
|
-
|
|
Mar 01
2021
|
Kristin Yarema Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,021
+27.51%
|
-
|
|
Mar 01
2021
|
Joe Newell Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,715
+20.83%
|
-
|
|
Mar 01
2021
|
Amar Murugan EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,756
+30.0%
|
-
|
|
Mar 01
2021
|
Jakob Dupont EVP, Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
53,879
+34.98%
|
-
|
|
Feb 08
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
3,886
-3.55%
|
$77,720
$20.39 P/Share
|
|
Feb 08
2021
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,759
-1.33%
|
$35,180
$20.39 P/Share
|
|
Jan 15
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
7,000
-6.01%
|
$126,000
$18.84 P/Share
|
|
Jan 15
2021
|
Joe Newell Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+2.92%
|
$42,000
$12.15 P/Share
|
|
Dec 16
2020
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
7,000
-2.96%
|
$161,000
$23.11 P/Share
|
|
Dec 16
2020
|
Joe Newell Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+2.83%
|
$42,000
$12.15 P/Share
|
|
Nov 17
2020
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
4,716
-1.81%
|
$89,604
$19.77 P/Share
|
|
Nov 17
2020
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
1,648
-1.39%
|
$31,312
$19.77 P/Share
|
|
Nov 17
2020
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,469
-1.1%
|
$27,911
$19.77 P/Share
|
|
Nov 13
2020
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
7,500
-3.01%
|
$135,000
$18.74 P/Share
|
|
Nov 13
2020
|
Joe Newell Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+2.71%
|
$42,000
$12.15 P/Share
|